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––– Abstract ––– 
 Chemical structure on the surface of materials determines the physicochemical properties such 
as solubility and binding affinity to other materials. Noncovalent immobilization of functional 
molecules to the surface is often utilized for the modification of materials due to the facility in 
operation. For example, surface functionalization of self-assembled objects is often achieved by 
solvophobic interactions in solution. In another case, nanocarbon materials can be noncovalently 
functionalized by using chemically-modified aromatic molecules through π–π interaction. However, 
these noncovalent approaches often lack the control of interactions at the molecular level precision 
and cause nonspecific adsorption of the molecules to the surface. In addition, the ill-controlled 
molecular immobilization methods often induce destabilization of self-assembled objects and 
decrease in cost-effectiveness of the surface modification. Therefore, more precise surface 
functionalization methods are needed. 
 In this thesis, I developed two kinds of supramolecular surface modification methods to 
overcome these problems. First one is post-surface modification of a self-assembled nanocapsule 
composed of a fluorous fullerene amphiphile via fluorous interaction. Second one is shape-selective 
surface modification of a nanocarbon via host-guest interaction. Specific structure on a nanocarbon 
surface was selectively modified with cyclodextrins (CDs), which are common host molecules for 
encapsulation of small guest molecules, and the water-dispersibility of the nanocarbon was 
improved by the addition of small amount (1 wt%) of CDs. In addition, the host-guest complex of 
nanocarbon and CD was visualized by high-resolution transmission electron microscopy (TEM) at a 
single molecule level. A functional group on CD was also visualized by TEM.  
 
 Chapter 1 describes non-covalent modification methods for surface nanostructures and the 
applications. Ligand display on self-assembled capsules and molecular adsorption on nanocarbons 
are highlighted. In addition, electron microscopic analysis of single organic molecules using 
nanocarbons as a template is discussed. 
 
 Chapter 2 describes protein-ligand display on the surface of sub-micrometer-sized fluorous 
fullerene vesicle via fluorous interaction. The vesicle composed of fluorous fullerene amphiphile 
that has three different moieties, perfluoroalkyl side chains/potassium cyclopentadienide /fullerene 
core, (Rf5C60–K+). When the amphiphile forms the vesicular structure, the perfluoroalkyl side chains 
are exposed to the surface of the vesicle in water. Therefore fluorous-tagged protein ligands can be 
immobilized on the surface of the vesicle via fluorous interaction simply by mixing them in water. 
In addition, the vesicle bound to target proteins via the surface ligands. 
  ii 
 Chapter 3 describes shape-selective surface modification of a nanocarbon via host-guest 
interaction of CDs. Carbon nanohorn (CNH) aggregates are 50–150 nm-sized aggregates of 
cone-shaped carbon nanotubes. The size of cone-shaped tip of CNH is almost the same size as 
[60]fullerene. CDs are usually used as a host molecule for encapsulation of small guest molecules 
in water. In particular, γ-CD is known to encapsulate fullerenes into its inner cavity and forms a 
stable water-soluble complex. Inspired by the shape-selective encapsulation of CDs, I achieved 
selective modification of the tip of CNH aggregates with γ-CD and the derivatives. Since γ-CD is 
hydrophilic molecule, hydrophobic CNH aggregates became dispersable in water upon 
complexation with γ-CD. The complex structures of γ-CD and a tip of CNH were first visualized by 
TEM at a single-molecule level with atomic resolution. In addition, this tip-selective molecular 
immobilization on CNH aggregates was applied to visualization of specimens bound to primary 
hydroxyl group of γ-CD.  
 
 Finally, chapter 4 summarizes the present thesis and describes possible outcomes for the 
chemistry of noncovalent functionalization of self-assembled objects and solid materials that have 
specific surface nanostructures.   
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 Chemical structure on the surface of materials determines the physicochemical properties such 
as solubility and binding ability to other materials. Modification of the surface with hydrophilic 
groups increases the solubility in water, and modification with surface ligand induces binding 
materials to specific protein. Therefore a variety of surface modification methods have been 
developed for functionalization of materials in materials science. Especially, noncovalent 
modification with functional small molecules is energetically studied due to its facility in the 
operation compared with covalent methods. Here I introduce noncovalent surface modification 
methods focusing on functionalization for self-assembled objects and nanocarbons.  
1.1. Noncovalent Modification of Self-Assembled Objects 
 Amphiphilic molecules such as surfactants,1 lipids2 and ionic brock copolymers3 composed 
of hydrophilic head and hydrophobic tail moieties form self-assembled objects. Amphiphilic 
molecules assemble in proper solvent via solvophobic interaction. In the case of self-assembly in 
water, amphiphilic molecules form micelle, bilayer vesicle, or bilayer sheets orienting the 
hydrophobic tails inside of the structure depending on the packing structure in self-assembly.4 
Generally, conical surfactants and ionic block copolymers tend to form micelles, while rod-shaped 
ionic block copolymers and lipids tend to form bilayer structures (Figure 1-1).3b, 5  
 
 
Figure 1-1. Relationship between the geometric structures of amphiphilic molecules and the self-assembled structures. 
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Hydrophobic molecules can be incorporated into the hydrophobic interior of self-assembled objects 
made from amphiphiles, while hydrophilic molecules can be encapsulated into the inner cavity of 
vesicles at pre- and post-formation of the structures in water (Figure 1-2a).2, 3b, 6 As an application 
using this phenomena, micelles and vesicles that contain drug molecules on the inside are used as a 
drug carrier to suppress metabolization of drugs and to add sustained release property in 
pharmacotherapy.3b, 7 In addition, the surface of the vesicles is modified by incorporation of 
functional molecules via hydrophobic interaction, for instance, ligand modification for binding to 
protein, cationic modification for immobilization of DNA, and light-harvesting antenna for 
responsiveness to light irradiation and construction of bio-mimetic materials (Figure 1-2b).8 
 
Figure 1-2. Incorporation of molecules into bilayer vesicles. (a) Incorporation of molecule such as drug molecules into 
the inside of vesicles and (b) display of functional molecules on the surface of vesicles. 
 
 Ligand functionalization on the surface of self-assembled objects has attracted much attention 
in the field of chemical biology.9 Since vesicles have capsular structure, they can contain both 
hydrophilic and hydrophobic drugs on the inside of the cavity and the membrane, respectively. In 
addition, their size can be adjusted to the suitable size (10–100 nm) for drug delivery to tumor 
cells.10 Therefore, vesicles are widely studied as a drug carrier in drug delivery system.10a, 11 
Modification of the surface of vesicles with protein-binding ligand molecules as “address labels” 
enables them to be delivered to the target diseases cells. Amphiphilic protein ligands that are 
composed of protein-binding moiety (conventionally saccharides) and hydrophobic tag moiety such 
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as alkyl, and adamantyl are immobilized on the membrane of the vesicles via hydrophobic 
interaction and host-guest interaction in water, respectively (Figure 1-3).8b, 8c, 12  
 
 
Figure 1-3. Ligand display on the surface of vesicles. (a) Aliphatic-tagged saccharides. (b) Ligand display on the 
surface of a lipid vesicle via hydrophobic interaction. (c) Functionalization of a cyclodextrin vesicle via host-guest 
interaction. 
 
 Hydrophilic saccharides moiety is displayed on the surface of the vesicles (Figure 1-3b, c) and 
binds to the target protein.12 However, immobilization of the protein ligands into the membrane of 
vesicles, especially liposomes, often destabilizes the membrane structure due to competitive 
interactions between the membrane formation and the ligands immobilization (Figure 1-4).13  
 In the chapter 2 in this thesis, I demonstrate a facile ligand display method on the surface of 
bilayer vesicles without affecting the structural integrity by using self-assembled fullerene bilayer 
as a scaffold.  
 
Figure 1-4. Destabilization of the membrane structure of vesicles due to competitive uptake of ligand molecules. 
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1.2. Noncovalent Modification of Nanocarbons 
 Nanocarbons such as fullerenes,14 carbon nanotubes (CNTs),15 and graphene16 have much 
attention in materials science due to the unique electrochemical properties17 and the robust 
molecular architecture17a, 18 derived from the large network of π system (Figure 1-5). Many 
modification methods of nanocarbons have been developed to adjust the chemical properties to their 
usages. Noncovalent modification is more manageable method than covalent modification because 
it does not break the π system and keep the chemical properties of nanocarbons.  
 
 
Figure 1-5. Structures of nanocarbons. 
 
 Generally, noncovalent surface modification of nanocarbons are performed by using long 
aliphatic molecules19 or chemically-modified aromatic molecules such as porphyrin,20 styrene,21 
and pyrene22 through hydrophobic interaction and π–π interaction (Figure 1-6a–c).23 Bowl-shaped 
and cage-shaped host molecules such as corannulene,24 calixarenes,25 and cyclodextrins26 form an 
inclusion complex with fullerenes by recognition of the size and the curved structure of the 
fullerenes via host-gest interaction (Figure 1-6d).27  In addition, cyclic aromatic rings are also 
known to encapsulate fullerenes on the inside (Figure 1-6e).28 Compared with fullerenes that can 
be handled as a molecule, however, noncovalent surface modification of CNTs and graphene cannot 
be controlled very well due to the bulk nature of the materials. Functional molecules are randomly 
physisorbed on the surface of CNTs and graphene, hence the amount and orientation of the 
adsorbed molecules are difficult to investigate (Figure 1-6b, c). 
 Nanocarbons dissolve neither in hydrocarbon nor polar solvents. Even if they are dissolved, 
they are easily agglomerated in the solution or dispersion liquid. This agglomeration is a severe 
problem that impedes further functionalization and the following applications. Therefore, 
improvement of their wettability is often to become a topic of their functionalization.19, 21, 26, 29 
Especially, dispersion and de-bundling of CNTs are widely studied in both organic solvents and 
aqueous solvents because of the importance in application.30 Pyrene with an aliphatic pendant was 
adsorbed on the surface of CNTs through the pyrene moiety and it improved the dispersibility of 
CNTs in organic solvents such as DMF and methanol (Figure 1-6c).22a Surfactants and amphiphilic 
block copolymers are also adsorbed on the surface of CNTs with the hydrophobic tail and made 
fullerene carbon nanotube graphene
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them dispersed in aqueous solvents (Figure 1-6b).19, 21 However, large amount of dispersants, at 
least as much as CNTs, are necessary for the dispersion of CNTs, which often cause bad effects in 
the physicochemical properties because noncovalent interaction between nanocarbon surface and 
dispersants usually weak and conventional dispersants aggregates into the self-assembled structure 
not adsorb on the surface of nanocarbons. In addition, the dispersants are difficult to be removed 
completely.  
 In the chapter 3 in this thesis, I try to develop a shape-selective surface modification method of 
a nanocarbon to overcome the general problem of nonspecific adsorption of functional molecules 
on the surface. 
 
 
Figure 1-6. Noncovalent modification of nanocarbons via π-π interaction. Molecules interact with nanocarbons via (a, 
b) multivalent interactions, (c) monovalent interaction, and (d, e) host-guest interactions. 
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1.3. Electron Microscopic Visualization of Single Molecules Using Nanocarbons 
 Electron microscopic imaging of the nanometer-sized structure and the behavior of organic 
molecules give us a new insight to understand the boundary between single molecule-level events 
and bulk properties of materials. However, the visualization of single organic molecules has been 
thought to be impossible by transmission electron microscopy (TEM) due to the significant damage 
of the specimens by electron irradiation during TEM measurement. 31  In contrast, fullerene 
molecules and the derivatives incorporated in CNTs, fullerene peapod, were stably observed by 
TEM because of isolation of fullerenes in CNTs (Figure 1-7a).32  Series of TEM images taken with 
a small time interval successfully traced the translational and the rotational motions of fullerenes,33 
and also, the dimerization and the carbon-carbon bond reorganization reactions of fullerenes (Figure 
1-7b).34  
 
 
Figure 1-7. TEM visualization of specimens on the inside of CNTs. (a) Fullerene peapod, Reprinted from ref. 32c, 
Copyright © 2005 American Chemical Society. (b) C–C bond reorganization of fullerenes under electron irradiation. 
Reprinted from ref. 34b, Copyright © 2011 American Chemical Society. (c) Hydrocarbon-attached ortho-carborane 
(left: TEM image, middle: simulation image of the TEM image). Reprinted from ref. 35a, with permission from AAAS. 
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The stereotype for TEM visualization has been broken by success in observation of 
hydrocarbon-attached ortho-carborane by using CNTs as a cage to fixation (Figure 1-7c).35a The 
rotational motions, the conformational changes, and the motion of organic molecules induced by 
interaction with the wall of CNTs were also observed.35 In this strategy, however, the specimen 
molecules should be incorporated into the inside of CNTs. The incorporation is carried out by 
vacuum vapor deposition,35 therefore molecules that cannot be vaporized and cannot be tolerated 
under high temperature are not available. In addition, the observed molecules are limited by the size 
of the diameter of CNTs. These problems reduce the versatility of the single molecule TEM 
visualization.   
 The limitation of TEM visualization using CNTs was overcome using carbon nanohorn (CNH) 
aggregates36 as another specimen support. CNH aggregates are 50–150 nm-sized aggregates of 
cone-shaped CNTs. Since the tip of CNH is more reactive than the sidewall due to the highly 
carved and strained π system, specimen molecules that are activated by succinimide ester were 
covalently bound to the tip of CNH via amide bonding (Figure 1-8a).37 
 
Figure 1-8. TEM visualization of specimens on the outside of CNTs (CNH). (a) Schematic illustration of specimen 
binding to amino CNH. TEM images of (b) biotinylated molecule and (c) cluster of dibromophenylbenzamide and 
tribromophenylbenzene. (b) Reprinted from ref. 38c, Copyright © 2015 American Chemical Society, (c) Reprinted 
from ref. 38b, Copyright © 2012 Macmillan Publishers Limited. All Rights Reserved. 
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Perfluorocarbon, biotinylated molecule, and Y-shaped dibromophenylbenzamide were observed in 
near-atomic resolution by TEM and their conformational changes were investigated (Figure 1-8b, 
c).35d, 38 This imaging technique is mild enough to take sequential image of van der Waals clusters 
of organic molecules (Figure 1-8c). 38b Because of the smaller spatial limitation than inside of CNTs, 
larger specimen molecules succeeded in applying to TEM observation, and its more dynamic 
motion was observed on the tip of CNH. The molecular dynamics was quantified by 
cross-correlation (γ) between consecutive each two frames of the movie of TEM images, and it was 
revealed that the motion was depending on acceleration voltage of TEM (Figure 1-9). 38c However, 
the modification yield on CNH via covalent bonding is very low, and it is quite difficult to confirm 
that specimen molecules are really immobilized of the tip before TEM observation. 
 In the chapter 3 in this thesis, I discuss shape-selective surface modification of CNH by high 
resolution TEM imaging. In addition, I developed a new methodology for immobilization of 
specimen on the tip of CNH using noncovalent interaction.  
 
Figure 1-9. Quantification of molecular dynamics of specimens observed by TEM. (a) Representative sequential TEM 
images of biotinylated molecule. (b) Cross correlation calculated from consecutive frames of the movie of TEM images 
in a. Reprinted from ref. 38c Copyright © 2015 American Chemical Society. 
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2.1. Introduction: Fullerene Vesicle and the Surface Modification 
 Sub-100 nm-sized nanocapsules are very attractive as a drug carrier due to the capsular 
structure and the suitable size to avoid metabolization in human body.1 Conventionally, liposomes 
made of lipid amphiphiles (molecules composed of polar head and nonpolar tail (s)) and 
polymersomes made of amphiphilic polymers are used as a drug carrier in pharmacotherapy.2 
Ligand display on the surface of the self-assembled capsules enables them to bind to a specific 
membrane protein of target diseased cells for the efficacy control. However, immobilization of the 
protein ligands into a membrane of the self-assembled capsules, especially liposomes, often 
destabilizes the membrane structure due to competitive interactions between the membrane 
formation and the ligand immobilization.3 Polymersomes also have a problem in the clinical usages, 
because polymers are usually difficult to be metabolized and tend to remain in tissues to cause toxic 
effects. The desirable features of the nanocapsules for practical application are 1) being composed 
of small molecules, 2) having robust membrane to tolerate further functionalization, and 3) being 
easily modified. 
 Nakamura et al. reported that water-soluble pentasubstituted [60]fullerene amphiphiles (R5C60–
K+) form sub-100 nm-sized self-assembled vesicles in water (Figure 2-1).4 The amphiphiles are 
composed of ternary architecture of alkyl or (perfluoro)alkyl side chains (nonpolar), potassium 
cyclopentadienide (polar), and fullerene core (nonpolar).4b The functional groups are synthetically 
introduced to the para-position of the substituted benzene ring. Due to the robust molecular 
structure of the fullerene core, the amphiphiles self-assemble into mechanically stable bilayer or 
interdigitated bilayer fullerene vesicles via π-π interaction. In addition, the substituted groups of the 
fullerene amphiphile are exposed to outside of the vesicle in water even though these are 
hydrophobic (perfluoro)alkyl groups.5 Therefore, the surface of the vesicle can be functionalized 
by designing the substituted groups of the fullerene amphiphiles. Formation of the vesicles was 
analyzed by not only light scattering in solution but also electron microscopy such as scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM) under vacuum. Due to the 
high stability of fullerenes and the structure robustness of the vesicles, the vesicular structure is 
maintained on substrates after drying, and the surface nanostructures were clearly observed in SEM.  
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Figure 2-1. Fullerene vesicle composed of water-soluble pentasubstituted fullerene amphiphiles. 
 
 Previously, Nakamura et al. reported a covalent construction method using Huisgen 
cycloaddition reaction of alkynyl vesicle, C8(7Y)K vesicle, and azide-terminated biotin molecule.6 
They demonstrated binding of avidin on the vesicle surface. Structural robustness of the fullerene 
vesicle enabled the surface modification and the following protein binding at post-formation of the 
vesicular structure. The adsorbed avidin on the surface of vesicle was clearly observed by extreme 
high resolution SEM without dissociation of the vesicle (Figure 2-2). Doxorubicin, an anticancer 
drug, was delivered into HepG2 cell (liver carcinoma) in vitro by encapsulation into the inner cavity 
of biotinylated fullerene vesicle and showed cytotoxicity, but the fullerene vesicle did not show 
cytotoxicity. Other fullerene vesicle composed of Ph5C60–K+ also showed low cytotoxicity.7 
However, isolation of the biotin-coated vesicle is necessary after the Huisgen cycloaddition reaction, 
and the efficacy of the cycloaddition reaction was low (20% based on the alkynyl group). I 
surmised that development of noncovalent surface modification method of fullerene vesicles would 
solve this operation issue. In this chapter, I demonstrate that a noncovalent fluorous modification 
method enabled dense functionalization of the surface of fullerene vesicle. 
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Figure 2-2. Formation and SEM imaging of protein-coated nanocapsules. Preparation of a biotinylated fullerene vesicle 
from fullerene amphiphile C8(7Y)K via Huisgen cycloaddition reaction and conjugation with avidin. (Right bottom) 
SEM images of avidin-coated vesicles coated on a microcrystalline ITO (indium-tin oxide)/glass substrate, Pale blue 
arrows denote avidin molecules. The SEM image is reprinted from ref. 6 with permission of The Royal Society of 
Chemistry. 
 
 Fluorous fullerene vesicle V1 composed of water-soluble fluorous fullerene amphiphile F8K 
(R5C60–K+, R = 4-heptadecafluorooctylphenyl, Figure 2-3) has large potential as a template for 
ligand display because of the fluorous nature. F8K self-assembles in water and forms vesicular 
structure with exposing their (perfluoro)octyl chains to an outer aqueous phase. Since fluorous 
compounds are specifically dissolved in fluorous solvents rather than water and non-fluorous 
organic solvents due to the small dielectric constant, fluorous-tagged (FT) molecules that are 
molecules bearing a perfluoroalkyl group, can be immobilized on fluorous surface in a noncovalent 
manner. It is known that FT-saccharides can be easily immobilized on the surface of a 
fluorous-modified glass slide8 and a polytetrafluoroethylene membrane filter9, both of which have 
highly fluorinated surface, via fluorous interaction.10 This immobilization method is applied to a 
simple ways of solid-phase synthesis of polysaccharide11, production of michroarray8, and detection 
of virus9. 
 Herein, I applied this fluorous modification method for ligand display on vesicle V1 to develop 
more facile noncovalent surface modification methods of self-assembled nanocapsule without 
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destabilization of the membrane structure. The ternary architecture of F8K enables to use 
orthogonal noncovalent interactions for membrane formation of V1 (π-π interaction) and ligand 
display on the surface of V1 (fluorous interaction). In addition, due to the immiscibility of 
(perfluoro)alkyl group, alkyl group, and properly designed FT-ligand molecules can be effectively 
displayed on the surface of the vesicle for the following protein binding. These well-constructed 
molecular designs in both the vesicle and the ligand molecule developed a non-invasive method for 
ligand display and protein binding on self-assembled nanocapsule. A part of this research has been 
already reported in my master theses.12 
 
 
Figure 2-3. A fluorous fullerene vesicle V1 composed of water-soluble fluorous fullerene F8K. SEM images of V1 
coated on a microcrystalline ITO/glass substrate. 
2.2. Preparation of Fullerene Vesicles and FT Molecules 
2.2.1. Synthesis of Fluorous Fullerene Amphiphile and FT Ligand Molecules 
 Penta(4-heptadecafluorooctylphenyl)[60]fullerene (F8H, R5C60H, R = 
4-heptadecafluorooctylphenyl) as a precursor of fullerene amphiphile F8K was firstly reported by 
Nakamura et al. in 2010.5 F8H was synthesized by pentaaddition reaction of [60]fullerene with 
1-bromo-4(heptadecafuluorooctyl)benzene through three organometallic intermediates, 
organolithium, organomagnesium, and organocopper derivatives of 
1-bromo-4(heptadecafuluorooctyl)benzene (Route A in Scheme 2-1). However, the three-step 
synthesis for the organocopper precursor of F8H made the operation difficult and often reduced the 
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reproducibility of the reaction because of instability of organometallic intermediates made of 
1-bromo-4(heptadecafuluorooctyl)benzene. Therefore I modified the synthetic procedure of F8H. I 
prepared the organocopper precursor in one-pot using 4(heptadecafuluorooctyl)-1-iodobenzene as a 
starting material and turbo Grignard reagent (iPrMgCl•LiCl complex) 13  to prepare the 
organomagnesium intermediate. F8H was synthesized this procedure with 70% yield and good 
reproducibility (Route B in Scheme 2-1). Penta(4-octylphenyl)[60]fullerene (C8H, R5C60H, R = 
4-octylphenyl) was synthesized to prepare an aliphatic fullerene vesicle V1C for aliphatic template 
for ligand display by the reported procedure.4b 
 
Scheme 2-1. Synthetic procedures of F8H. 
 
 
 Fluorous-tagged (FT)-mannopyranosides (FT-Man 1 and FT-Man 2) and alkyl-tagged 
(AT)-mannopyranoside (AT-Man 3) were synthesized by reaction of 
2,3,4,6-tetra-O-acetyl-a/b-D-mannopyranosidetrichloroacetimidate and the corresponding alcohols 
with reference of Pohl’s group paper8 (Scheme 2-2). FT-Man 1 is composed of a (perfluoro)octyl 
group and a longer aliphatic tether than FT-Man 2. These two ligands were designed to elucidate 
the orientation of immobilization of the FT molecules on the fullerene vesicles. Pohl et al. reported 
that the properly designed length of aliphatic tether was necessary for binding to a protein on 
fluorous glass surface.8 AT-Man 3 is designed to elucidate the importance of fluorous interaction 
for functionalization. FT-galactopyranoside (FT-Gal 4, synthesized by Mr. Mizuno, S.) was used as 
another ligand molecule for evaluation of the protein binding ability of the fullerene vesicles. 
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Scheme 2-2. Synthesis of (perfluoro)alkyl or alkyl-tagged saccharides. 
 
2.2.2. Preparation of Fullerene Vesicles 
 Preparation of fullerene vesicle V1 and V1C has been already reported by Nakamura group.4b 
Briefly, potassium salts of fullerene amphiphiles F8K (for V1) and C8K (for V1C) were prepared 
by deprotonation of F8H and C8H in THF, respectively. The solution of the potassium fullerene 
salt was slowly injected into water with stirring to obtain the vesicle solution. THF was removed by 
evaporation, and then the vesicle solution was diluted with water to adjust the concentration of the 
potassium fullerene salt to 1.0 mM in water (Scheme 2-3). The hollow vesicular structure of V1 in 
water was confirmed previously through combined dynamic and static light scattering analysis.4 
The average diameter of the vesicle V1 was determined to be 27.0 ± 0.5 nm (polydispersity index 
(PdI) of 0.15) by dynamic light scattering (DLS) measurement. The vesicle solution of C8K (V1C 
solution) was prepared by the same procedure and the concentration was adjusted to 1.0 mM. The 
average diameter of the vesicle V1C was determined to be 23.8 ± 0.1 nm (PdI: 0.15, Figure S2-1). 
 
Scheme 2-3. Schematic illustration of preparation of fullerene vesicle V1 and V1C. 
 
2.3. Ligand Display on Fullerene Vesicles 
 Perfluorinated surface of vesicle V1 was successfully modified with FT-Man 1 just by mixing 
the solutions (Figure 2-4). FT-Man 1 in water forms aggregates of an ill-defined µm-sized structure 
(Figure 2-4b, gray), and so do FT-Man 2 and the AT-Man 3 (See Figure S2-1 in supporting 
O
HO
HO
HO OH
O O (CF2)7CF3
(Gal)
O
AcO
AcO
AcO OAc
O
NH
CCl3
HO O (CF2)7CF3
HO O(CH2)10CH3
HO (CF2)7CF3
(1.5 eq)
or
or
Me3SiOTf (0.7 eq)
CH2Cl2, 0 ºC
O
AcO
AcO
AcO OAc
OR
K2CO3 (4 eq)
MeOH, rt
O
HO
HO
HO OH
OR
(Man)
O (CF2)7CF3
O(CH2)10CH3
FT-Man  1: R =
AT-Man 3: R =
FT-Man  2: R = (CF2)7CF3 29%
33%
23%
FT-Gal 4 (in 2 steps)
Chapter 2 
 23 
information.) measured by DLS measurement. Upon mixing the solution of 1 into V1 ([1]:[F8K] = 
1:1 mole ratio), the aggregates mostly disappeared, and instead there formed a uniform solution of 
V2 that showed a DLS peak with an average diameter of 32.8 ± 0.8 nm (PdI of 0.15, Figure 2-4b, 
red). Compared with the average diameter of V1 (27.0 ± 0.5 nm, Figure 2-4b, black), the 5.8 ± 0.7 
nm increase in the diameter of V2 indicates that the mannopyranoside and the alkyl tether moieties 
of 1 are displayed on the surface of V1. The size increase of V1 is larger than the expected value 
from the molecular size of the mannopyranoside and the alkyl tether moieties of 1 (ca. 1.5 nm x 2 
molecules = 3.0 nm), suggesting that V1 was slightly swollen by insertion of the (perfluoro)octyl 
group of 1 into the membrane of V1.14 
 
 
Figure 2-4. Surface coating of V1 with FT-Man 1 in water. (a) Schematic illustration of display of 1 on V1, (b) DLS 
data for V1 (black), an aggregate of 1 (gray) and a mixture of V1 and 1 at [F8K]:[1] = 1:1 mole ratio (red) recorded at 
25 °C. The zeta potentials of V1 and V2 ([F8K]:[1] = 1:5 mole ratio) at pH 7.4 were –40 mV and –60 mV, respectively. 
 
 Ligand display on the fullerene vesicles was evaluated further with other combinations of the 
vesicle and the ligand molecule by size increase of the vesicles. The size increase of the vesicles 
upon binding of the ligand molecules is summarized in Table 2-1. Upon mixing FT-Man 2 that has 
short alkyl tether into the solution of vesicle V1, size increase corresponding to the 
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mannopyranoside moiety was detected. However mixing AT-Man 3 into the solution V1 did not 
show size increase of V1. This result suggests that 3 was not adsorbed on the surface of V1 due to 
the immiscibility of alkyl group of 3 and (perfluoro)alkyl group of F8K. When aliphatic fullerene 
vesicle V1C was used as a template for ligand display, 3.1 ± 0.2 nm or 3.3 ± 0.2 nm of size increase 
of V1C was detected by mixing FT-Man 1 or 3 into the solution of V1C, respectively. The value of 
size increase indicates that both 1 and 3 were adsorbed on the surface of V1C via hydrophobic 
interaction but did not induce swelling of V1C like combination of V1 and 1. I surmise that the 
(perfluoro)octyl group and octyl group of 1 and 3 were not inserted into the membrane of V1C, 
hence V1C modified with 1 or 3 does not show significant protein binding ability on the vesicle as 
shown in next section. 
 
Table 2-1. Increase in the vesicle size upon addition of ligand molecules, e.g., by addition of 1 to V1. [fullerene] = 
[ligand] = 0.2 mM. Unit is nm. The measurement was carried out in triplicate and the error denotes standard error of 
mean. Original DLS data is shown in Figure S2-1 in supporting information. 
 
 The maximum amount of FT-Man 1 which can be adsorbed on the surface of vesicle V2 was 
estimated by interfacial tension measurement using pendant drop method. Briefly, a droplet of 
sample solution was hanged on the tip of a syringe needle and interfacial tension of the sample was 
calculated by analysis of the shape of the droplet using the equation of Bashforth and Adams which 
is based on Laplace’s equation (Figure S2-3).12b F8K amphiphile did not show interfacial activity 
because it does not exist as a monomer in water even though it was very low concentration (< 0.1 
µM) due to the formation of the rigid vesicle structure (Figure 2-5b). Therefore, the fullerene 
amphiphile is not adsorbed to the air-water interface and does not show interfacial activity. In 
contrast, since 1 is composed of hydrophilic mannopyranoside moiety and hydrophobic fluorous tag 
moiety, 1 shows surface activity in water as a surfactant. In water, 1 is adsorbed to air-water 
interface and decreases the interfacial tension (Figure 2-5a, B). In contrast, in V1 solution, 1 is 
adsorbed to the fluorous surface of V1 first, and after saturation on the surface of V1, 1 starts to be 
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adsorbed on the air-water interface and decreases the interfacial tension of V1 solution. The 
maximum amount of 1 on V1 was estimated by measuring difference in the critical aggregation 
concentration (CAC) that indicates saturation of the air-water interface of droplet of 1 in water 
(19.1 ± 1.4 mM, Figure 2-5c, red) and in V1 solution (24.1 ± 1.3 mM, Figure 2-5c, blue). This 
difference of 5.0 ± 1.9 mM in the CAC of 1 indicates the saturation (maximum) amount of 1 on the 
surface of V1 ([F8K] = 1.0 mM).  
 
Figure 2-5. Quantitative evaluation of the amount of FT-Man 1 on the surface of vesicle V1 by interfacial tension 
measurement using a pendant drop method. (a) Expected illustration of interfacial tension change upon increase of 
concentration of 1. A: No change in interfacial tension (a interfacial tension of pure water at 25 ºC), B: Decrease of 
interfacial tension due to adsorption of 1 to air-water interface, C: No change in interfacial tension due to saturation at 
air-water interface with 1. (b) Interfacial activity of V1 in water. (c) Interfacial activity of 1 in water (red) and 1 in a 
solution of vesicle V1 (1.0 mM for F8K, blue). The measurement was carried out in triplicate and the error denotes 
standard error of mean. The CAC of 1 increases by 5.0 ± 1.9 mM because of adsorption of 1 on V1. 
 
Assuming that the water-soluble 1 does not penetrate the fullerene bilayer and according to 
molecular modeling of the membrane structure of V2 saturated with 1 (Figure 2-6),6 I conclude that 
approximately eight molecules of 1 per F8K are located outside, hence there were approximately 
three molecules of 1/nm2 on the surface of a vesicle (6890 molecules on V1 with 27.0 nm diameter). 
FT-Gal 4 was also loaded on the surface of V1 with the same maximum density as 1 (Figure 2-7). 
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The ligand molecules are densely packed at this density as we can see in the molecular modeling 
(Figure 2-6).  
 
 
Figure 2-6. Molecular modeling of V2 ([F8K]:[1] = 1:8), where FT-Man 1 is densely packed on the F8K membrane. 
(a) Side view and (b) top view. The van der Waals models of F8K and 1 are shown in green and red, respectively. 
Potassium ions of F8K are omitted for clarity. 
 
 
Figure 2-7. Interfacial tension measurements of FT-Gal 4. Interfacial tension change in FT-Gal 4 in water (red) and 4 in 
a solution of vesicle V1 (1.0 mM for F8K, blue). CAC values of 4 increased by 5 mM due to absorption of 4 on V1. 
This result suggests that the maximum loading ratio of 4 on V1 is 5:1. Error bar means standard error (N =3). 
 
 Structure robustness of vesicle V2 in solution was evaluated by heating at 80 °C for 24 h 
traced visually and by DLS. Neither aggregation nor precipitation occurred. As studied by SEM 
(See Figure S2-2 in supporting information and Figure 2-14a.), V2 maintains its spherical structure 
even in air and under vacuum conditions. The spherical structure was also maintained upon atomic 
force microscopic (AFM) analysis on mica in air (Figure 2-8a), and on scanning transmission 
electron microscopy (STEM) on a thin carbon film under vacuum (Figure 2-8b). Contrast profile of 
V2 in the STEM image shows a unimodal curve (Figure 2-8b, right) that indicates that V2 retained 
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the contents of the inside. From these results, therefore, V2 is very robust like vesicle V1, 
suggesting that the immobilization of the fluorous saccharides does not destabilize the bilayer 
membrane. 5 
 
Figure 2-8. Microscopic images of V2. (a) AFM image of V2 on mica. Cross section diagram of V2 (right, pale blue 
line in the left image). (b) STEM image of V2 on an amorphous carbon film (ca. 6 nm thickness) at an acceleration 
voltage of 200 kV. Contrast profile of V2 (right, pale blue line in the left image). 
2.4. Protein Binding on Ligand-Coated Fullerene Vesicles  
 Protein binding on ligand-coated fullerene vesicles with concanavalin A (ConA, a lectin binds 
to mannose) was next probed according to the known protocol for assessment of sugar–protein 
binding on a vesicle (Figure 2-9).15 Addition of a buffer solution of ConA (2.0 µM, pH 7.2) to a 
solution of V2 (V1 + FT-Man 1; [F8K] = [1] = 20 µM) increases the turbidity of the solution due to 
spontaneous agglomeration of V3 originating in the cross-linking of the vesicles via tetravalent 
ConA (Figure 2-9b, red).15 Methyl α-D-mannopyranoside (3,000 eq) was added as an inhibitor for 
binding between 1 and ConA after 20 min when the turbidity increase reached plateau. The 
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turbidity of the solution was decreased that means partially destroy of the network structure of V3 
agglomerates. This result indicates that ConA binds to the surface of V1 via 1. In contrast, V1 
bearing FT-Man 2 or AT-Man 3, and V1C bearing 1 or 3 did not show significant turbidity increase 
after addition of ConA (Figure 2-10a).  
 
Figure 2-9. Time evolution of the turbidity of the solution upon addition of ConA to a mixture of V1 and FT-Man 1. 
The turbidity was monitored by measurement of the optical density at λ = 500 nm ([fullerene] = 20 µM). (a) Schematic 
illustration of ConA binding on vesicle V2 (V1 bearing 1) via 1. (b) Turbidity change for a mixture of V1 and 1 
([F8K]:[1] = 1:1, red). Addition of 3,000 eq of methyl α-D-mannopyranoside at 20 min resulted in a decrease in 
turbidity (red). The blue and the green lines are control experiments for V1 and 1, respectively. Photoabsorption of F8K 
is subtracted from the optical density as a background.  
 
According to the size increase of V1 upon the ligand display (Table 2-1), 2 was immobilized of the 
surface of V1 but the mannopyranoside moiety was not properly displayed to bind to ConA (Figure 
2-10b), and 3 was not immobilized on the surface of V1. Therefore ConA did not bind to these 
vesicles and no significant turbidity increase was observed (Figure 2-10a, gray and orange for V1 + 
2 and V1 + 3, respectively). 
  As shown in the section 2-3, size of V1C was increased upon mixing of 1 and 3 
corresponding to display of the ligands on the surface of V1C. However, neither V1C bearing 1 
(Figure 2-10a, green) nor V1C bearing 3 (Figure 2-10a, blue) showed significant turbidity increase. 
Mismatching alkyl-(perfluoro)alkyl combination of C8K of V1C and 1, and alkyl-alkyl 
combination of C8K and 3 are too weak to immobilize ConA on the surface of the vesicles. These 
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ligand molecules are easily detached from the surface of the vesicles when hydrophilic ConA binds 
and makes the molecules dissolved into water (Figure 2-10c). As a result, it is obviously revealed 
that fluorous interaction enables proper ligand display and the following protein binding on the 
vesicle. Note that nonspecific binding of V1 to the proteins exists but negligible (Figure 2-9b, blue). 
	 
 
Figure 2-10. Time evolution of the turbidity of the solution upon addition of ConA to a mixture of V1 or V1C and FT- 
or AT-Man. The turbidity was monitored by measurement of the optical density at λ = 500 nm ([fullerene] = 20 µM). 
(a) Turbidity change for a mixture of vesicle V1 or V1C, and FT- or AT-Man ([fullerene]:[Man] = 1:1). The 
background contribution of the nonspecific binding to V1 (Blue line in Figure 2-9b) is subtracted. Surface structure of 
ligand display on fullerene vesicles, (b) V1 (F8K membrane), and (c) V1C (C8K membrane) expected by size increase 
of the vesicles upon mixing ligand molecules (Table 2-1). 
 
 I also confirmed that vesicle V1 bearing FT-Gal 4 has strong interaction with peanut agglutinin 
(PNA, A protein binds to galactose.) by turbidity measurement (Figure 2-11). Then the protein 
binding selectivity was evaluated by using FT-Man- and FT-Gal-coated vesicles.12a Since the V1 
coated with 1 selectively binds to ConA (Figure 2-12a), the vesicle coated with 4 binds to PNA 
(Figure 2-12b). The lower selectivity in the experiment in Figure 2-12b is due to the poorer 
selectivity of ConA than PNA.16 V1 decorated with a 1:1 mixture of 1 and 4 bound to both ConA 
and PNA (Figure 2-12c). The slow rate of binding of PNA (Figure 2-12c, blue) is consistent with 
the reported data.17 These results suggested that dual modification of V1 with different ligand 
molecules was succeeded by just mixing each solution via fluorous interaction, and the 
dual-modified vesicle recognized two different proteins. 
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Figure 2-11. Time-dependent turbidity change after mixing proteins with ligand molecule-coated vesicles monitored by 
optical density at λ = 500 nm. We started to record the optical density at the point of addition of proteins (0 min). 
Concentration of fullerene amphiphiles was fixed to 20 mM. Absorption of the V1 at 500 nm was independently 
measured at subtracted from the optical density as a background. (a) Turbidity change upon mixing PNA with V1 
incorporating 4 ([F8K]:[4] = 1:1, red), and PNA with V1 (blue). At 20 min, 1500 eq of D-(+)-galactose was added as an 
inhibitor of binding between 4 and PNA (dashed line). 
 
 
Figure 2-12. Recognition of two different proteins by V1 decorated with FT-Man 1 and FT-Gal 4. (a) Turbidity 
increase for V1 + 1 and ConA (red) or PNA (blue) ([F8K]:[1] = 1:1). (b) For V1 + 4 and ConA or PNA ([F8K]:[4] = 
1:1). (c) For V1 + 1 + 4 ([F8K]:[1]:[4] = 1:0.5:0.5). A turbidity decrease was observed when methyl 
α-D-mannopyranoside and D-(+)-galactose were added to the solutions of V1 + 1 + 4 mixed with ConA and PNA, 
respectively (See Figure S2-5 in supporting information.). The background contribution of the nonspecific binding to 
V1 is subtracted. 
 
 Density of FT-saccharides displayed on the surface of vesicle V1 can be easily tuned up to 
eight molecules of FT-saccharides per F8K. By changing the sugar density on the vesicle surface, it 
was found that there is an optimum sugar density for optimum protein binding (Figure 2-13). As 
4
4
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shown in the red line of a combination of ConA and FT-Man 1-coated vesicle, the turbidity increase 
maximizes at a 1/F8K ratio of 0.6 (i.e., approximately proportional to sugar/surface area and ca 
0.43 molecule/nm2). At a higher ligand density, the binding ability vanished. A similar trend was 
also observed for the PNA binding to FT-Gal 4-coated vesicle with the binding maximizing at 
[4]/[F8K] = 1.4 (i.e., approximately proportional to sugar/surface area and ca 1.0 molecule/nm2, 
Figure 2-13, blue). Assuming closest hexagonal packing of the ligand molecules on the surface of 
V1, the optimum ratio of 1 on V1 for ConA binding is a distance of 3.3 nm among each molecule 
and that is 4 on V1 is a distance 2.1 nm. These values are close to the known values for spatial 
separation of the ConA and PNA binding sites, 3.6–3.9 nm18 and 2.4–3.0 nm19, respectively. 
Appropriate spacing between the ligand moiety on the vesicle is necessary for proteins to bind to 
the saccharide moiety of ligand molecules on the vesicle surface.  
 
 
Figure 2-13. Dependence of turbidity on sugar density on the vesicle surface measured for combinations of ConA and 
V1-coated FT-Man 1 (red) and PNA and V1-coated with FT-Gal 4 (blue). The vertical axis refers to the optical density 
of the solution after subtraction of the contribution of nonspecific binding to V1. 
2.5. SEM and STEM Imaging of Lectin-Coated Fullerene Vesicles 
 High resolution SEM provided visual evidence that V1 maintained its spherical structure after 
addition of FT-Man 1 and ConA. FT-Man 1-coated vesicle V2 and protein-binding vesicle V3 were 
spin-coated on an IZO (indium-zinc oxide)/glass substrate. After addition of ConA into V2 solution, 
V3 forms and gradually agglomerates into micrometer-sized network structures. To visualize 
isolated V3, V3 was sampled at 1 min after addition of ConA when the turbidity of the solution 
have not reached plateau (cf. Figure 2-9b). Surface of IZO is very smooth and hydrophilic that 
supports the visualization of nanometer-sized vesicles clearly and the isolation of the vesicle on the 
surface (Figure S2-2). The SEM analysis was carried out using electron beam current of 6.3 pA at 
low beam landing voltage (200 V) to avoid signal generation from deep inside of the vesicles. 
Surface of V2 is very smooth (Figure 2-14a), whereas that of V3 is rough (Figure 2-14b). ca. 10 
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nm-sized objects are observed on the surface of V3 (indicated with red circles in Figure 2-14c) that 
is corresponding to ConA (8 nm).20 But the spherical structure of the vesicle is still maintained. 
SEM image of V3 sampled 20 min after addition of ConA shows network structures, but even after 
agglomeration, the spherical structure of vesicles is also maintained. In addition, STEM image 
shows that vesicles with dark black contrast were agglomerated via ConA with gray contrast 
without loss of the contents of the inside (Figure 2-14e). These results indicate that the ligand 
display, the protein binding, and the agglomeration did not break the vesicular structure of V1. 
Modification of vesicular vectors with ligand molecules bearing a hydrophobic insertion chain and 
large amount of proteins usually greatly reduces the mechanical stability of the vesicles.3,21 In this 
case, however, mutually orthogonal molecular interactions, π-π interaction and fluorous interaction, 
were applied for driving forces of vesicle formation and ligand binding, respectively. Therefore V2 
and V3 kept their spherical structure after the modification.  
 
 
Figure 2-14. SEM and STEM images of vesicle V3 (V2 bearing ConA). SEM images of V2 (V1 bearing FT-Man 1), 
V3, and the network of V3 were recorded on an IZO/glass substrate at a landing voltage of 200 V. The imaging under 
these conditions does not require the conventional metal coating of the sample. (a) V2, which is a perfect sphere and has 
a smooth surface (a mole ratio of F8K:1 = 1:1). Scale bar is 25 nm. (b) V3 sampled 1 min after mixing with ConA. (c) 
The same image as in b, where brighter areas because of ConA molecules are highlighted in red. Scale bar is 50 nm. (d) 
Agglomerated V3 sampled 20 min after mixing with ConA. Scale bar is 200 nm. (Inset) A magnified image where 
ConA molecules are seen to glue V3 to each other. Scale bar is 50 nm. (e) STEM image of the network of V3 recorded 
on an amorphous carbon film (ca. 6 nm thickness) at an acceleration voltage of 200 kV. Vesicles and ConA are denoted 
by red arrows. 
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2.6. Conclusion  
 In conclusion, a fluorous fullerene F8K vesicle and ligand display via fluorous interaction 
provide a viable approach to the preparation of structurally well-defined nanocapsules. Protein 
ligands are effectively displayed on the surface of the vesicle for the following protein binding. 
Spherical structure of the vesicle was maintained after the ligand display and the protein binding. 
The simplicity of the preparation, the structural robustness, and the utility of diversity of 
fluorous-tagged molecules are attractive for construction of a drug carrier in pharmacotherapy 
compared with conventional lipid systems. In addition, the fluorine-rich and fullerene-based 
functional vesicles are unique among water-soluble mesoscopic nanostructures and are expected to 
be applicable as bioimaging agents for 19F MRI22 and antioxidants.7 
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1. General 
 All reactions dealing with air- or moisture-sensitive compounds were carried out in a dry 
reaction vessel under nitrogen or argon atmosphere. The water content of the solvent was confirmed 
with a Karl-Fisher Moisture Titrator (MKC-210, Kyoto Electronics Company) to be less than 100 
ppm. Analytical thin-layer chromatography was perfumed on a glass plate coated with 0.25 mm 
230–400 mesh silica gel containing a fluorescent indicator (Merck). Analysis with high 
performance liquid chromatography (HPLC) was performed on JASCO HPLC system equipped 
with a Bucky Prep column (Nacalai Tesque Cosmosil Buckyprep, 4.6 × 250 mm; column 
temperature at 40 ºC). Flash silica gel chromatography was performed on silica gel 60N (Kanto, 
spherical and neutral, 140–325 mesh) as described by Still.1 Gel permiation chromatography (GPC) 
was performed on Japan Analytical Industry LC–908 (eluent: chloroform) with JAIGEL 1H and 2H 
polystyrene columns. Infrared (IR) were recorded on a ASI Applied System React IR1000 equipped 
with an attenuated total refraction (ATR) instrument or JASCO/ FT IR-420 and are reported as 
wavenumbers (υ) in cm-1. NMR spectra were measured on JEOL ECX-400 and ECA-500 
spectrometers and reported in parts per million from tetramethylsilane (TMS). 1H NMR spectra in 
CDCl3 were referenced internally to TMS as a standard and CS2 was used as a co-solvent for 
dissolution of fullerene pentaadducts, 13C NMR spectra to the solvent resonance. 
Hexafluorobenzene (δ = –162.0) was used as an internal standard for 19F NMR.2 Dynamic light 
scattering (DLS) study was carried out on a Malvern Zetasizer Nano ZS machine. Scanning 
transmission electron microscopy (STEM) was performed on a JEOL JEM-2100F (acceleration 
voltage: 200 kV). Atomic force microscope (AFM) measurement was performed by using JEOL 
JSPM-4200 with a silicon cantilever (NSC-35, resonant frequency 120–190 kHz). The 
time-dependent turbidity changes were recorded on a JASCO V-570 UV/Vis/NIR 
Spectrophotometer. 
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2. Materials 
 Unless otherwise noted, materials were purchased from Tokyo Kasei Co., Aldrich Inc., and 
other commercial suppliers and used after appropriate purification before use. Anhydrous ethereal 
solvents (stabilizer-free) were purchased from WAKO Pure Chemical and purified by a solvent 
purification system (GlassContour)3 equipped with columns of activated alumina and supported 
copper catalyst (Q-5) prior to use. All other solvents were purified by distillation and stored over 
molecular sieves 4 Å. Distilled water was further purified with Millipore Milli-Q. F8K vesicle 
(V1)4 and C8K vesicle (V1C)5 were prepared according to the reported procedures. 
 
6,9,12,15,18-Penta(4-heptadecafluorooctylphenyl)-1,6,9,12,15,18-hexahydro(C60-In) 
[5,6]fullerene (F8H) 
 
 The synthesis of F8H was firstly reported by Nakamura et al. in 2010.4 Herein a modified 
procedure for facile synthesis of F8H is described. 4-(heptadecafluorooctyl)-1-iodobenzene (435 
mg, 0.700 mmol) in THF (0.35 mL) was added to Turbo Grignard reagent; a solution of 
iPrMgCl•LiCl in THF (1.08 M, 1.04 mL, 1.12 mmol) over 10 min at –20 oC. After stirring for 1 h at 
–20 ºC, the solution was transferred through a cannula to a suspension of CuBr•SMe2 (230 mg, 1.12 
mmol) in THF (0.60 mL) at –20 oC, and then the mixture was stirred for 10 min at –20 ºC. A 
solution of C60 (25.0 mg, 35.0 µmol) in 1,2-dichlorobenzene (1.27 mL) was transferred through a 
cannula to the mixture at –20 oC. After stirring for 1 h at 35 oC, saturated aqueous ammonium 
chloride solution (1 mL) was added to the solution. The suspension was concentrated to remove 
THF and dimethyl sulfide. The concentrated mixture was filtered through a pad of silica gel (3 cm) 
with toluene and FC-72. The filtrate was concentrated on a rotary evaporator at 70 oC until 
precipitation occurred. Methanol was added until precipitation was complete. The precipitate was 
collected by membrane filter, washed with methanol, and dried under reduced pressure for 4 h to 
obtain an orange-red powder (80.2 mg) in 70 % yield. Analytical data is consistent with the reported 
ones.4  
 
 
(CF2)7CF3
(CF2)7CF3
(CF2)7CF3
CF3(CF2)7
HCF3(CF2)7
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1-O-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoxyl-cis-but-2-enyl)-α-man
nopyranoside (FT-Man 1) 
 
 1-O-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoxyl-cis-but-2-enyl)-2,3,4,
6-tetra-O-acetyl-α-mannopyranoside (56.5 mg, 64.3 µmol)6 and K2CO3 (31.5 mg, 228 µmol) was 
dissolved in MeOH (3 ml). The mixture was stirred for 30 min. The reaction mixture was 
neutralized using Amberlyst-15 ion-exchange resin and filtered. The solvent was removed under 
reduced pressure and desired product was obtained as a colorless sticky solid (39.6 mg, 55.7 µmol, 
87%): mp 180–181 ºC (dec); IR (powder) 3383, 2925, 2503, 1722, 1452, 1370, 1331, 1201, 1146, 
1134, 1104, 1059, 1031, 974, 877, 809, 779, 737, 721, 703, 655, 557 cm-1; 1H NMR (500 MHz, 
methanol-d4) δ 1.86–1.91 (m, 2H), 2.24–2.35 (m, 2H), 3.54–3.57 (m, 3H), 3.62 (dd, J = 9.7, 9.7 Hz, 
1H), 3.69–3.71 (m, 2H), 3.81 (dd, J = 1.7, 3.4 Hz, 1H), 3.86 (dd, J = 2.3, 12.0 Hz, 1H), 4.11–4.31 
(m, 4H), 4.81 (d, J = 1.7 Hz, 1H), 5.72–5.77 (m, 2H); 13C NMR (125 MHz, methanol-d4) δ 21.91, 
28.88 (t, JCF = 23 Hz), 62.95, 63.59, 67.49, 68.64, 69.68, 72.20, 72.63, 74.84, 100.76, 129.52, 
131.03; 19F NMR (470 MHz, methanol-d4) δ –124.87 (2F), –122.03 (2F), –121.31 (2F), –120.50 
(4F), –120.31 (2F), –113.05 (2F), –79.97 (3F); Anal. Calcd for C21H23F17O7: C, 35.51; H, 3.26. 
Found: C, 35.22; H, 3.52. 
 
1-O-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoxyl)-α-mannopyranoside 
(FT-Man 2) 
 
 To a solution of 2,3,4,6-tetra-O-acetyl-α/β-D-mannopyranosidetrichloroacetimidate7 (211 mg, 
0.428 mmol) and 1H,1H,2H,2H,3H,3H-perfluoroundecanol (138 mg, 289 µmol) in 
dichloromethane (5 mL) were cooled down to 0 ºC. TMSOTf (41.8 mg, 188 µmol) was added and 
the reaction mixture was stirred at 0 ºC for 30 min. The reaction was quenched with triethylamine 
(1 mL). The crude product was purified by solid-phase extraction using a fluorous solid-phase 
extraction cartridge (Fluorous Technologies, Inc.). Non-fluorous compounds were eluted with 80% 
MeOH/water and fluorous compounds was eluted by 100% MeOH. The solvent was removed under 
reduced pressure. Whole amount of the fluorous compounds (193 mg) and K2CO3 (149 mg, 1.08 
mmol) were dissolved in MeOH (7.5 mL). The mixture was stirred at rt for 2 h. The reaction 
O
C8F173
O
HO
HO
HO OH
O
O
HO OH
HO
HO
O
C8F173
Chapter 2 
 40 
mixture was neutralized using Amberlyst-15 ion-exchange resin and filtered. The solvent was 
removed under reduced pressure and desired product was purified by flash column chromatography 
on silica gel using Hexane/EtOAc and EtOAc/MeOH as eluent. The desired product was obtained 
as a colorless sticky solid (50.0 mg, 78.0 µmol, 29%): mp 205–206 ºC; IR (powder) 3317, 2927, 
2855, 2360, 2340, 1739, 1435, 1366, 1262, 1146, 1102, 1026, 977, 809, 705, 657, 557 cm–1; 1H 
NMR (500 MHz, methanol-d4) δ 1.85–1.95 (m, 2H), 2.23 (tt, J = 19, 9.0 Hz, 2H), 3.48–3.54 (m, 
2H), 3.60 (t, J = 9.5  Hz, 1H), 3.67–3.72 (m, 2H), 3.80–3.86 (m, 3H), 4.77 (d, J = 1.2 Hz, 1H); 13C 
NMR (125 MHz, methanol-d4) δ 21.77, 28.91 (t, JCF = 22 
Hz), 62.94, 66.99, 68.55, 72.13, 72.64, 74.89, 101.65; 19F NMR (470 MHz, methanol-d4) δ –
124.77 (2F), –121.90 (2F), –121.22 (2F), –120.41 (4F), –120.22 (2F), –112.83 (2F), –79.85 (3F); 
HRMS (FAB+): Calculated for [C17H17F17O6Na]+: 663.0651, found: 663.0637. 
 
4-undecanoxyl-cis-2-buten-1-ol 
 
 
 cis-1,4-butenediol (0.330 mg, 3.50 mmol) and crushed KOH (304 mg, 5.42 mmol) were added 
to distilled DMF (15 mL). Undecyl iodide (800 mg, 2.83 mmol) was added to the solution at rt and 
then the reaction mixture was heated at 65 ºC for 2 h. The reaction was quenched with HCl (1N) 
after dilution with water (30 mL). The organic layer was extracted with EtOAc (30 mL x 3) and 
dried over brine (10 mL) and MgSO4. The mixture was filtered and the solvent was removed under 
reduced pressure. The crude product was purified by flash column chromatography on silica gel 
using Hexane/EtOAc as eluent. The desired product was obtained as an yellow oil (549 mg, 2.27 
mmol, 81%): IR 3368, 2923, 2853, 2360, 2340, 1722, 1466, 1380, 1106, 1029, 721 cm–1; 1H NMR 
(500 MHz, CDCl3)  δ 0.88 (t, J = 7.2 Hz, 3H), 1.26–1.30 (m, 16H), 1.56–1.61 (m, 2H), 1.96 (t, J = 
5.7 Hz, OH), 3.44 (t, J = 6.6 Hz, 2H), 4.05 (d, J = 6.3 Hz, 2H), 4.21 (dd, J = 5.7, 5.7 Hz, 2H), 5.72 
(dt, J = 11, 5.7 Hz, 1H), 5.83 (dt, J = 11, 6.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.10, 22.67, 
26.14, 29.32, 29.46, 29.56, 29.59 (2C), 29.70, 31.89, 58.83, 66.47, 70.91, 128.65, 132.02; HRMS 
(ESI+): Calculated for [C15H30O2Na]+: 265.2138, found: 265.2136. 
 
1-O-(undecanoxyl-cis-but-2-enyl)-α-mannopyranoside (AT-Man 3) 
 
 To a solution of 2,3,4,6-tetra-O-acetyl-α/β-D-mannopyranosidetrichloroacetimidate (296 mg, 
HO OC11H23
O
HO OH
HO O OC11H23
HO
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603 µmol)7 and 4-undecanoxyl-cis-2-buten-1-ol (121 mg, 500 µmol) in dichloromethane (10 mL) 
were cooled down to 0 ºC. TMSOTf (77.8 mg, 350 µmol) was added and the reaction mixture was 
stirred at 0 ºC for 1.5 h. The reaction was quenched with triethylamine (0.1 mL) after dilution with 
water (20 mL). The organic layer was extracted with dichloromethane (10 mL x 3) and dried over 
brine (10 mL) and MgSO4. The mixture was filtered and the solvent was removed under reduced 
pressure. The crude product (400 mg) and K2CO3 (277 mg, 2.00 mmol) were dissolved in MeOH 
(15 mL). The mixture was stirred at rt for 1 h. The reaction mixture was neutralized using 
Amberlyst-15 ion-exchange resin and filtered. The solvent was removed under reduced pressure 
and desired product was purified by flash column chromatography on silica gel using 
Hexane/EtOAc and EtOAc/MeOH as eluent. The desired product was obtained as an yellow waxy 
oil (67.0 mg, 166 µmol, 33%): IR (powder) 3331, 2924, 2854, 2360, 2341, 1650, 1459, 1353, 1230, 
1071, 975, 835, 736, 678 cm–1; 1H NMR (500 MHz, methanol-d4) δ 0.89 (t, J = 6.9 Hz, 3H), 1.29–
1.32 (m, 16H), 1.56 (tt, J = 7.2, 7.1 Hz, 2H), 3.44 (t, J = 6.6 Hz, 2H) 3.53–3.56 (m, 1H) 3.65 (td, J 
= 9.7, 1.7 Hz, 1H), 3.71–3.75 (m, 2H), 3.82–3.85 (m, 2H), 4.08 (d, J = 4.6 Hz, 2H), 4.11–4.15 (m, 
1H), 4.25–4.28 (m, 1H) 4.81 (s, 1H) 5.70–5.73 (m, 2H); 13C NMR (125 MHz, methanol-d4) δ 14.43, 
23.72, 27.25, 30.46, 30.58, 30.72 (3C), 30.77, 33.06, 62.90, 63.69, 67.37, 68.60, 71.59, 72.20, 72.60, 
74.74, 100.75, 129.39, 131.13; HRMS (ESI+): Calculated for [C21H40O7Na]+: 427.2666, found: 
427.2677. 
 
1-O-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoxyl-cis-but-2-enyl)-2,3,4,6-
β-galactopyranoside (FT-Gal 4) 
 
 1-O-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoxyl-cis-but-2-enyl)-2,3,4,
6-tetra-O-acetyl-α-galactopyranoside (10.1 mg, 11.5 µmol)7 and K2CO3 (7.5 mg, 54 µmol) was 
dissolved in MeOH (1 ml). The mixture was stirred for 2 h. The reaction mixture was neutralized 
using Amberlyst-15 ion-exchange resin and filtered. The solvent was removed under reduced 
pressure and desired product was obtained as a colorless sticky solid (7.5 mg, 11 µmol, 88%): mp 
81.5–82.5 ºC; IR (powder) 3502, 3337, 2933, 2870, 1731, 1452, 1372, 1332, 1200, 1146, 1114, 
1077, 1058, 1041, 974, 920, 861, 780, 738, 721, 704, 655, 622, 558 cm-1; 1H NMR (500 MHz, 
methanol-d4) δ 1.86–1.92 (m, 2H), 2.24–2.35 (m, 2H), 3.47–3.57 (m, 5H), 3.74–3.85 (m, 5H), 4.28 
(d, J = 8.1 Hz, 1H), 4.33 (dd, J = 6.9, 12.6 Hz, 1H), 4.45 (dd, J = 5.75, 13.2 Hz, 1H), 5.72–5.83 (m, 
2H); 13C NMR (125 MHz, methanol-d4) δ 21.87, 28.87 (t, JCF = 23 Hz), 62.55, 65.48, 67.50, 69.66, 
O
HO
HO
HO OH
O O
C8F173
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70.33, 72.47, 75.02, 76.78, 103.86, 129.52, 131.03; 19F NMR (470 MHz, methanol-d4) δ –124.87 
(2F), –122.03 (2F), –121.31 (2F), –120.50 (4F), –120.31 (2F), –113.05 (2F), –79.97 (3F); Anal. 
Calcd for C21H23F17O7: C, 35.26; H, 3.26. Found: C, 35.40; H, 3.43. 
 
Preparation of fullerene vesicles 
 The vesicle solution of F8K (V1 solution) used for the studies was prepared as reported4: 
Potassium tert-butoxide in THF (1.0 M, 35.2 mL, 35.2 µmol) was added to a suspension of F8H 
(23.4 µmol) in THF (1.84 mL) and the mixture was stirred under nitrogen. During the mixing, the 
suspension became a dark transparent solution of F8K. After 3 h, a portion of the solution of F8K 
(12.5 mM, 1.60 mL, 20 µmol) was slowly injected into water (8.4 mL) with stirring at 400 rpm over 
1 min using a syringe pump (ISIS Co.) to obtain a vesicle solution of F8K (2.0 mM) in 16 % 
THF/water. THF was removed by evaporation, and then the vesicle solution was diluted with water 
using 25 mL measuring flask. The final concentration of vesicle V1 was determined to be 1.0 mM 
by UV-Vis absorption measurement. The average diameter of the vesicle V1 was determined to be 
27.0 ± 0.5 nm (PdI: 0.15) by DLS measurement. The vesicle solution of C8K (V1C solution) was 
prepared by the same procedure and the concentration was adjusted to 1.0 mL. The average 
diameter of the vesicle V1C was determined to be 23.8 ± 0.1 nm (PdI: 0.15).   
 
Typical procedure of preparation of V2 
 A stock solution of FT-Man 1 (0.50 mM, 0.12 mL) was mixed with F8K (0.33 mM) vesicle 
(V1) solution (0.18 mL) and the mixture was stirring using a magnetic stirrer over 10 min at 200 
rpm ([1] = [F8K] = 0.20 mM). Increase in diameter of the vesicle and disappearance of signal 
originating in 1 were observed by DLS analysis, suggesting adsorption of 1 on V1 (i.e. formation of 
V2). 
 
3. Measurements 
DLS measurements 
DLS measurement was performed by using Malvern Zetasizer Nano ZS equipped with an He–
Ne laser operating 4 mW power and 633 nm wavelength, and a computer-controlled correlator, at a 
173º accumulation angle. Measurements were carried out in polystyrene or glass cuvette. The data 
were processed using Dispersion Technology Software version 5.10 to give Z-average particle size 
and polydispersity index (PdI) value by cumulant analysis, and particle size distribution with high 
resolution (Multiple narrow mode). 
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Figure S2-1. DLS analysis of fullerene vesicles, V1 and V1C, coated with 1, 2, and 3 ([sugar]/[fullerene] = 1:1). (a) V1 
+ 1, (b) V1+ 2, (c) V1 + 3, (d) V1C + 1, (e) V1C + 3. Error means standard error (N =3). Aggregates of 1, 2, and 3 are 
shown as black line. 
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SEM measurement 
 Extreme high resolution scanning electron microscopy (SEM) was carried out using a FEI 
Magellan 400L. An aqueous solution of the V1, V2, and V3 ([V1] = 0.02–2 mM) was spin-coated 
on an IZO/glass substrate cleaned by UV/ozone pretreatment. After drying under reduced pressure 
(5 × 10–2 Pa) for 10 min, the substrates were subjected to the SEM observation at a beam landing 
voltage of 200 V with a beam deceleration bias of 800 V under a vacuum of 5 × 10–5 Pa without 
any conductive coatings. 
 
Figure S2-2. SEM images of fullerene vesicles on an IZO/glass taken at beam landing voltage of 200 V and beam 
current of 6.3 pA. (a) V2, (b) V3, (c) agglomerated V3. The vesicles are the round objects surrounded by shadow and 
the irregular objects in b are the crystalline fine structures of IZO or excess ConA.  
 
500 nm
200 nm
100 nm
a b
c
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AFM measurement 
AFM measurement was conducted on a JEOL JSPM-4200 with a silicon cantilever 
(NSC-350, resonant frequency 120–190 kHz). Samples were deposited on mica substrate (5 x 5 
mm2) in aliquot of 2 mL under air. After drying the sample by blowing air for 10 sec and under 
reduced pressure (5 x 10–2 Pa), the AFM images were obtained with AC mode measurement. 
 
STEM measurement 
A solution (2 µl) of F8K vesicle (50 µM) or the mixture of F8K, FT-Man 1, and ConA 
([F8K] = [1] = 50 µM, [ConA] = 1.8 µM) in water was dropped on TEM copper grids pre-coated 
with super-ultra-high-resolution carbon supported films (thickness: ca 6 nm, Oken Shoji Co. Inc.), 
and the substrate was dried without blotting in a desiccator overnight. The STEM observation at 
298 K was performed on a JEOL JEM-2100F with a spherical aberration coefficient Cs = 1.0 mm at 
an acceleration voltage of 200 kV under reduced pressure of 1.0 × 10–5 Pa in the sample column. 
The current density was ca 0.5 pA•cm–2. The imaging instrument used was an ultrascan 
charged-coupled device (CCD) camera (512 × 512 pixels). 
 
Interfacial tension measurement 
Interfacial tension measurements were performed using a DM-301 (Kyowa Interface 
Science Co. Ltd.) and analyzed by FAMAS software. FT-Man 1 was weighted in a plastic tube and 
dissolved in F8K (1.0 mM) vesicle (V1) solution (200 µL) by stirring using a magnetic stirrer over 
10 min at 200 rpm. Interfacial tension at each concentration was measured by the pendant drop 
method.8 The droplet of sample solution was hanged down from the tip of syringe and the 
interfacial tension  (γ)	 was calculated from the captured image of the droplet using the equation 
of Bashforth and Adams which is based on Laplace’s equation (eq.1). 1𝑅! 𝑎 + sin𝜑𝑥 𝑎 = −𝐵 𝑧𝑎 + 2                              (eq. 1)  
where a is the radius of curvature at the apex of the drop, x, z and f are the coordinates defined as in 
Figure S2-3, and B is given by eq.2.                                         𝐵 = 𝑎!𝑔∆𝜌𝛾                                             (eq. 2)  
where Δρ is the difference between the densities of the pendant drop and air, g is the gravitational 
constant, Interfacial tension of 1 was measured three times at each concentration of 1. Error was 
calculated as standard error of the interfacial tension. The CAC values were obtained from an 
intersection of two regression curves (Figure S2-4). The maximum density of 1 on the V2 surface 
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was estimated from increase of critical aggregation concentration (CAC) of 1. The maximum 
density of FT-Gal 4 was also obtained in the same way as 1. 
 
Figure S2-3. Pendant drop method to measure interfacial tension. 
 
 
  
Figure S2-4. Interfacial tension measurements of FT-Man 1. Interfacial tension change in 1 in water (red) and 1 in a 
solution of vesicle V1 (1.0 mM for F8K, blue). CAC values of 1 increased by 5 mM due to absorption of 1 on V1. This 
result suggests that the maximum loading ratio of 1 on V1 is 5:1. Error bar means standard error (N =3). 
 
Molecular modeling of V2 
 Molecular structure of F8K was optimized by molecular mechanics calculations using 
Compass force field implemented in Materials Studio.9 The surface area per one F8K molecule 
that consists of outer part of the V1 vesicle was estimated to be 3.80 nm2 from SLS measurements.4b 
Using hexagonal closest packing lattice of F8K with spatial separation of 2.10 nm between the 
neighboring molecules generated on Materials Studio, eight FT-Man molecules 1 per one F8K 
molecule were placed on F8K layer manually not to overlap with F8K molecule and other 
FT-molecules within the sum of van der Waals radii. 
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Turbidimetry experiments10 
 Concanavalin A (ConA) and peanut agglutinin (PNA): Turbidimetry experiments were 
performed in a quartz cell (1×1 cm). Aliquot (500 µL) of stock ConA or PNA solutions (1 mg/ mL) 
in HEPES buffer (10 mM, pH 7.1, [NaCl] = 150 mM, [CaCl2] = 1 mM, [MnCl2] = 1 mM) was 
diluted with the same HEPES buffer (1700 mL). The 1: 1 mixture as a molar ratio of F8K or C8K, 
and FT-Man 1 or the 1: 1 mixture as a molar ratio of F8K and FT-Gal 4 in Milli-Q (300 µL) was 
added. The mixture was stirred at 1000 rpm at 20 ºC and UV spectra were measured every 10 sec. 
The turbidity of the mixtures was monitored by plotting absorbance at 500 nm. After 20 minutes, an 
excess amount of inhibitor in HEPES buffer (150 µL of 1 M solution of Me–α–D-mannopyranoside 
for ConA, 150 µM of 0.5 M of D-(+)-galactose) was added. The absorbance after addition of the 
inhibitor was corrected in consideration of the effect of dilution. The same vesicle solution was 
used for a series of experiment for avoidance of effect of the size distribution.  
 
 
Figure S2-5. Time-dependent turbidity change upon mixing proteins with solution of V1 coated both with FT-Man 1 
and FT-Gal 4. The measurements were carried out using the same condition mentioned above. (a) Turbidity change 
upon mixing ConA with a solution V1 coated with 1 and 4 ([F8K]:[1]:[4] = 1:0.5:0.5, red), and ConA with a solution of 
V1 (blue). At 20 min, 3000 eq of methyl α-D-mannopyranoside was added as an inhibitor of binding between 1 and 
ConA (dashed line). (b) Turbidity change upon mixing PNA to F8K vesicle solution incorporating 1 and 4 
([F8K]:[1]:[4] = 1:0.5:0.5, red), and PNA with V1 (blue). At 20 min, 3000 eq of D-(+)-galactose was added as an 
inhibitor of specific binding between 4 and PNA (dashed line).  
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 In the present thesis, I developed two kinds of precisely controlled supramolecular surface 
modification methods in molecular-level to overcome long-standing problems on noncovalent 
modification of self-assembled objects and nanocarbons resulting from nonspecific binding of 
functional molecules on their surface. One is post-surface modification of a self-assembled capsule 
via fluorous interaction that does not affect to the structural integrity of the capsule. Another is 
shape-dependent surface modification of a nanocarbon via host-guest interaction that enable us to 
functionalize it with high efficacy to the control of the physicochemical properties. 
 
 In chapter 2, protein-ligand display on the surface of sub-micrometer-sized fluorous fullerene 
vesicle via fluorous interaction was achieved without decreasing the mechanical stability of the 
membrane of the vesicle even after binding with proteins. Vesicle made of fluorous fullerene 
amphiphile are composed of a bilayer of amphiphilic fullerene where the fullerene core is located in 
the interior, perfluoroalkyl substituents are exposed to an aqueous environment, and the anionic part 
is located in the middle. Because of the unique fluorous/polar/fullerene (nonpolar) ternary 
architecture that enables hierarchical construction of vesicles by orthogonal interactions, 
fluorous-tagged saccharides as ligands for proteins were successfully immobilized on the fluorous 
surface of the vesicle via fluorous interaction just mixing the sample solutions (Figure 4-1).  
 
Figure 4-1. Ligand display on a self-assembled nanocapsule via fluorous interaction. 
 
Because of the robust fullerene membrane and immiscibility of heavy fluorous molecules with 
non-fluorous molecules, only the fluorous tag moiety was incorporated into the fluorous surface 
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without penetration to the fullerene membrane, and the hydrophilic saccharide moiety and the 
aliphatic tether moiety were successfully displayed on the surface of the vesicles that enables them 
to be bound to the target proteins strongly.  
 Fluorous interaction was crucial for the ligand display and the following protein binding on the 
surface of the vesicle via ligand-protein interaction. This precision immobilization and the display 
of ligand molecules preserved the mechanical stability of the fullerene membrane that retains the 
vesicular structure even after binding with proteins on the surface of the vesicle confirmed by high 
resolution scaning-electron microscopy (SEM) measurements that can reveals the surface 
morphology of self-assembled objects (Figure 4-2). The protein ligand-decorated fluorine-rich and 
fullerene-based functional vesicles are expected to be applicable in medicinal applications. 
 
Figure 4-2. High resolution SEM measurement of ligand-decorated vesicle (left) and protein-binding vesicle (right). 
SEM measurement was performed on a smooth IZO/glass substrate at low landing voltage 200 V.  
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